Tests that measure 'biological age' aren't helpful for tracking your health, scientists say
Scientists warn that "biological age" tests, though popular, are unreliable for personal health tracking. Current evidence shows these tests lack precision for individual use, though they may offer b…
Tests advertised as measures of "biological age" are increasingly popular with consumers seeking a snapshot of their long-term health, but scientists
Read Full Story at Live Science →Why This Matters
The growing commercialization of "biological age" tests has fueled a false sense of precision in personal health monitoring, distracting consumers from evidence-based interventions like diet, exercise, and medical screenings. While these tests exploit curiosity about aging, their reliance on biomarkers that fluctuate for reasons unrelated to health—such as recent illness or stress—risks misinforming decisions on everything from retirement planning to medical treatments.
Background Context
Biological age testing emerged from research in epigenetics and DNA methylation, where scientists identified patterns in gene expression linked to aging. Commercial tests simplified these findings into consumer-friendly metrics, often marketed as predictors of lifespan or disease risk. However, the field remains in its infancy, with no standardized methodology or validation against longitudinal health outcomes—unlike traditional health markers like blood pressure or cholesterol.
What Happens Next
Expect regulatory scrutiny to intensify as these tests gain traction, particularly if consumer complaints or misleading claims prompt action from bodies like the FDA or FTC. Companies may pivot to selling "longevity insights" as part of broader wellness packages, while insurers could incorporate biological age into risk models—raising ethical questions about discrimination based on perceived aging trajectories. Meanwhile, researchers will likely refine biomarkers, but widespread adoption of any single test remains years away.
Bigger Picture
This controversy reflects a broader tension in the wellness industry: the tension between cutting-edge science and market-driven hype. As tools like AI-driven health predictions and wearable biometrics proliferate, the gap between what’s technically possible and what’s clinically useful widens—often at the expense of public trust. The rise and fall of biological age tests may serve as a cautionary tale about commodifying uncertainty in human health.
